307
Participants
Start Date
November 26, 2014
Primary Completion Date
June 16, 2020
Study Completion Date
June 16, 2020
Nivolumab
specified dose and dosing schedule
Epacadostat
oral twice daily continuous at the protocol-defined dose
Chemotherapy
Specified dose on specified days
NYU Cancer Center, New York
Columbia University, Herbert Irving Comprehensive Cancer Center, New York
University of Pittsburgh School of Medicine, Pittsburgh
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Wake Forest Medical Center Boulevard, Winston-Salem
Duke University Medical Center, Durham
UAB Comprehensive Cancer Center, Birmingham
Vanderbilt University Medical Center, Nashville
Medical College of Wisconsin, Milwaukee
Sanford Research, North Sioux City
Sanford Research, Fargo
The University of Kansas Clinical Research Center, Fairway
MD Anderson Cancer Center, Houston
Texas Oncology Research, Austin
University of Colorado Anschutz Medical Campus, Aurora
Utah Cancer Specialists, Salt Lake City
Huntsman Cancer Institute, Salt Lake City
The Angeles Clinic and Research Institute, Los Angeles
USC Norris Cancer Center, Los Angeles
UCSF - University of California San Francisco, San Francisco
Dana Farber Cancer Institute, Boston
Lahey Hospital & Medical Center, Burlington
The Christie NHS Foundation Trust, Manchester
Oxford University Hospitals NHS Trust, Oxford
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Incyte Corporation
INDUSTRY